{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:54:21Z","timestamp":1790888061567,"version":"4.1.0"},"reference-count":15,"publisher":"Universidad Nacional de C\u00f3rdoba","issue":"3","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Fac Cien Med Univ Nac Cordoba"],"abstract":"<jats:p>La malabsorci\u00f3n hereditaria de folato (MHF) es un defecto metab\u00f3lico de herencia autos\u00f3mica recesiva causado por variantes patog\u00e9nicas en SLC46A1, gen que codifica el transportador de folato asociado a protones. Este defecto altera la absorci\u00f3n intestinal de folato y su transporte al SNC, produciendo deficiencia cerebral de folato a\u00fan con niveles s\u00e9ricos normales. Cl\u00ednicamente, se manifiesta con anemia megalobl\u00e1stica, s\u00edntomas gastrointestinales, alteraciones inmunol\u00f3gicas y compromiso neurol\u00f3gico progresivo. La determinaci\u00f3n de 5-metiltetrahidrofolato (5-MTHF) en LCR constituye el m\u00e9todo diagn\u00f3stico espec\u00edfico, el tratamiento se basa en la administraci\u00f3n de \u00e1cido fol\u00ednico o \u00e1cido levofol\u00ednico.\nCaso: paciente masculino, con inicio temprano de anemia microangiop\u00e1tica, retraso del desarrollo y epilepsia refractaria e hiperhomocisteinemia; se identific\u00f3 por exoma la variante patog\u00e9nica c.981_982del; p.Tyr327Ter en SLC46A1. Con el diagn\u00f3stico, se suspendi\u00f3 el \u00e1cido f\u00f3lico y se inici\u00f3 tratamiento con \u00e1cido fol\u00ednico, posteriormente reemplazado por \u00e1cido levofol\u00ednico intramuscular ante deterioro cl\u00ednico y disminuci\u00f3n de 5-MTHF en LCR. La\u00a0 estrategia terap\u00e9utica multimodal, permiti\u00f3 la normalizaci\u00f3n de biomarcadores y el control de la epilepsia refractaria.\nPrimer reporte de un caso argentino de MHF por mutaci\u00f3n en SLC46A1 asociada a deficiencia cerebral de folato. La detecci\u00f3n de epilepsia refractaria temprana e hiperhomocisteinemia fueron claves en la orientaci\u00f3n diagn\u00f3stica. El seguimiento mediante 5-MTHF en LCR result\u00f3 esencial para evaluar la respuesta terap\u00e9utica. El \u00e1cido levofol\u00ednico mostr\u00f3 mejor eficacia cl\u00ednica y bioqu\u00edmica que la leucovorina. Este caso ampl\u00eda el conocimiento genot\u00edpico-fenot\u00edpico de esta enfermedad y resalta la importancia del diagn\u00f3stico precoz y del manejo individualizado para optimizar la evoluci\u00f3n neurol\u00f3gica.<\/jats:p>","DOI":"10.31053\/1853.0605.v83.n3.50324","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:02:19Z","timestamp":1790715739000},"page":"e50324","source":"Crossref","is-referenced-by-count":0,"title":["Malabsorci\u00f3n hereditaria de folato por mutaci\u00f3n en &lt;i&gt;SLC46A1&lt;\/i&gt; con deficiencia cerebral de folato y epilepsia refractaria","Hereditary Folate Malabsorption Due to an &lt;i&gt;SLC46A1&lt;\/i&gt; Mutation with Cerebral Folate Deficiency and Refractory Epilepsy","M\u00e1 absor\u00e7\u00e3o heredit\u00e1ria de folato por muta\u00e7\u00e3o em &lt;i&gt;SLC46A1&lt;\/i&gt; com defici\u00eancia cerebral de folato e epilepsia refrat\u00e1ria","M\u00e1 absor\u00e7\u00e3o heredit\u00e1ria de folato por muta\u00e7\u00e3o em &lt;i&gt;SLC46A1 &lt;\/i&gt;com defici\u00eancia cerebral de folato e epilepsia refrat\u00e1ria"],"prefix":"10.31053","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7427-3317","authenticated-orcid":false,"given":"Carola Lucrecia","family":"Grosso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes Ver\u00f3nica","family":"Peralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6018-8883","authenticated-orcid":false,"given":"Marina","family":"Paviolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Pautasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2838-4694","authenticated-orcid":false,"given":"Guillermo Ariel","family":"Guelbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3873-4348","authenticated-orcid":false,"given":"Mar\u00eda del Pilar","family":"Bovina Martijena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2807-8806","authenticated-orcid":false,"given":"Laura Elena","family":"Lar\u00f3vere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"12333","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Alam C, Kondo M, O'Connor DL, Bendayan R. Clinical implications of folate transport in the central nervous system. Trends Pharmacol Sci. 2020 May;41(5):349-361. doi: 10.1016\/j.tips.2020.02.004","DOI":"10.1016\/j.tips.2020.02.004"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Wang Q, Li X, Ding Y, Liu Y, Qin Y, Yang Y. The first Chinese case report of hereditary folate malabsorption with a novel mutation on SLC46A1. Brain Dev. 2015 Jan;37(1):163-7. doi: 10.1016\/j.braindev.2014.01.010.","DOI":"10.1016\/j.braindev.2014.01.010"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Zhao R, Min SH, Wang Y, Campanella E, Low PS, Goldman ID. A role for the proton-coupled folate transporter (PCFT-SLC46A1) in folate receptor-mediated endocytosis. J Biol Chem. 2009 Feb 13;284(7):4267-74. doi: 10.1074\/jbc.M807665200.","DOI":"10.1074\/jbc.M807665200"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Ramaekers VT, Blau N. Cerebral folate deficiency. Dev Med Child Neurol. 2004 Dec;46(12):843-51. doi: 10.1017\/s0012162204001471.","DOI":"10.1017\/S0012162204001471"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Torres A, Newton SA, Crompton B, Borzutzky A, Neufeld EJ, Notarangelo L, Berry GT. CSF 5-methyltetrahydrofolate serial monitoring to guide treatment of congenital folate malabsorption due to proton-coupled folate transporter (PCFT) deficiency. JIMD Rep. 2015;24:91-6. doi: 10.1007\/8904_2015_445.","DOI":"10.1007\/8904_2015_445"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Kumar M, Yoganathan S, Todari S, Suresh P, Chandran M, Danda S, Mathew LG, Koshy B, Thomas M. Hereditary Folate Malabsorption: A Rare Treatable Disorder with Hematological and Neurological Manifestations. Ann Indian Acad Neurol. 2022 Nov-Dec;25(6):1238-1241. doi: 10.4103\/aian.aian_1118_21.","DOI":"10.4103\/aian.aian_1118_21"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Zhao R, Min SH, Qiu A, Sakaris A, Goldberg GL, Sandoval C, Malatack JJ, Rosenblatt DS, Goldman ID. The spectrum of mutations in the PCFT gene, coding for an intestinal folate transporter, that are the basis for hereditary folate malabsorption. Blood. 2007 Aug 15;110(4):1147-52. doi: 10.1182\/blood-2007-02-077099.","DOI":"10.1182\/blood-2007-02-077099"},{"key":"ref7","unstructured":"8. Goldman ID. Hereditary folate malabsorption. 2008 Jun 17 [updated 2024 Feb 15]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. PMID: 20301716."},{"key":"ref8","unstructured":"9. MedlinePlus Genetics. SLC46A1 gene: solute carrier family 46 member 1. Bethesda (MD): National Library of Medicine; Last updated May 22, 2024. En: https:\/\/medlineplus.gov\/genetics\/gene\/slc46a1\/"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Geller J, Kronn D, Jayabose S, Sandoval C. Hereditary folate malabsorption: family report and review of the literature. Medicine (Baltimore). 2002 Jan;81(1):51-68. doi: 10.1097\/00005792-200201000-00004","DOI":"10.1097\/00005792-200201000-00004"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Kishimoto K, Kobayashi R, Sano H, Suzuki D, Maruoka H, Yasuda K, Chida N, Yamada M, Kobayashi K. Impact of folate therapy on combined immunodeficiency secondary to hereditary folate malabsorption. Clin Immunol. 2014 Jul;153(1):17-22. doi: 10.1016\/j.clim.2014.03.014","DOI":"10.1016\/j.clim.2014.03.014"},{"key":"ref11","unstructured":"12. MedlinePlus Genetics. Hereditary folate malabsorption. Bethesda (MD): National Library of Medicine; Last updated May 22, 2024. En: https:\/\/medlineplus.gov\/genetics\/condition\/hereditary-folate-malabsorption\/"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Steinfeld R, Grapp M, Kraetzner R, Dreha-Kulaczewski S, Helms G, Dechent P, Wevers R, Grosso S, G\u00e4rtner J. Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. Am J Hum Genet. 2009 Sep;85(3):354-63. doi: 10.1016\/j.ajhg.2009.08.005","DOI":"10.1016\/j.ajhg.2009.08.005"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Lubout CMA, Goorden SMI, van den Hurk K, Jaeger B, Jager NGL, van Koningsbruggen S, Chegary M, van Karnebeek CDM. Successful treatment of hereditary folate malabsorption with intramuscular folinic acid. Pediatr Neurol. 2020 Jan;102:62-66. doi: 10.1016\/j.pediatrneurol.2019.06.009","DOI":"10.1016\/j.pediatrneurol.2019.06.009"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Manea E, Gissen P, Pope S, Heales SJ, Batzios S. Role of intramuscular levofolinate administration in the treatment of hereditary folate malabsorption: report of three cases. JIMD Rep. 2018;39:7-12. doi: 10.1007\/8904_2017_39.","DOI":"10.1007\/8904_2017_39"}],"container-title":["Revista de la Facultad de Ciencias M\u00e9dicas de C\u00f3rdoba"],"original-title":[],"link":[{"URL":"https:\/\/revistas.unc.edu.ar\/index.php\/med\/article\/download\/50324\/55980","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistas.unc.edu.ar\/index.php\/med\/article\/download\/50324\/55980","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:58:32Z","timestamp":1790884712000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistas.unc.edu.ar\/index.php\/med\/article\/view\/50324"}},"subtitle":["primer caso reportado en Argentina","First Case Reported in Argentina","primeiro caso relatado na Argentina"],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,8,4]]}},"URL":"https:\/\/doi.org\/10.31053\/1853.0605.v83.n3.50324","relation":{},"ISSN":["1853-0605","0014-6722"],"issn-type":[{"value":"1853-0605","type":"electronic"},{"value":"0014-6722","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,29]]}}}